Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Quest Diagnostics EPS Beats Expectations
Quest Diagnostics EPS Beats Expectations
Quest Diagnostics EPS Beats Expectations
Submitted by
admin
on October 22, 2024 - 11:23pm
Source:
Motley Fool
News Tags:
Quest Diagnostics
earnings
diagnostics
Headline:
Quest Diagnostics EPS Beats Expectations
snippet:
Quest Diagnostics reported revenues of $2.49 billion for Q3 2024, outperforming analyst expectations of $2.425 billion.
Adjusted diluted earnings per share (EPS) reached $2.30, also surpassing the estimated $2.26.
Adjusted operating income margins fell slightly from 16.6% to 15.5%, indicating cost pressure despite revenue growth.
Do Not Allow Advertisers to Use My Personal information